Who Paid My Doc
Stratagraft
Biological Critical Care
NDC 73612-200-01
General payments
$154,240
Research payments
$1,609,965
Through program year 2025, $154,240 in general payments and $1,609,965 in research payments were reported against Stratagraft (Critical Care).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,365 | 1 |
| 2024 | General | $26,225 | 5 |
| 2024 | Research | $172,449 | 35 |
| 2023 | General | $30,391 | 46 |
| 2023 | Research | $322,047 | 40 |
| 2022 | General | $51,116 | 124 |
| 2022 | Research | $394,845 | 57 |
| 2021 | General | $46,508 | 62 |
| 2021 | Research | $719,260 | 89 |
Breakdown
Each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2024 where a state was reported.
Records
237 general · 222 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.